Increased rebleeding and mortality in patients with gastrointestinal bleeding treated with anticoagulant drugs compared to antiplatelet drugs

Supplemental Digital Content is available in the text. Background/Aim We determined the effect of antiplatelet and anticoagulant agents on rebleeding and mortality in patients with gastrointestinal bleeding. Methods This was a prospective study of patients admitted with gastrointestinal bleeding between 2013 and 2018. Outcomes were compared among patients on antiplatelet agents only, anticoagulant drugs only, combination therapy, and none. The association between mortality, rebleeding, and type of antithrombotic medication on admission and discharge was determined using multivariate analysis. Results A total of 509 patients were followed up for a median of 19 months. End of follow-up rebleeding and mortality rates were 19.4% and 23.0%, respectively. Independent predictors of mortality were age [hazard ratio (HR) = 1.025 per year increase, P = 0.002], higher Charlson Comorbidity Index (HR = 1.4, P < 0.0001), severe bleeding (HR = 2.1, P < 0.0001), and being on anticoagulants (HR = 2.3, P = 0.002). Being on antiplatelets was protective against rebleeding (HR = 0.6, P = 0.047). Those on anticoagulants were more likely to die (HR = 2.5, P < 0.0001) and to rebleed (HR = 2.1, P = 0.01) than those on antiplatelets. Antithrombotic drug discontinuation upon discharge was associated with increased mortality in patients with cardiovascular disease. Conclusion In gastrointestinal bleeding, rebleeding and mortality were associated with being on anticoagulant drugs, while being on antiplatelet agents was protective against rebleeding. Discontinuation of antithrombotics upon discharge increased the risk of death. The findings inform risk stratification and decisions regarding continuation or discontinuation of antithrombotics.

[1]  L. Laine,et al.  Previous Use of Antithrombotic Agents Reduces Mortality and Length of Hospital Stay in Patients With High‐risk Upper Gastrointestinal Bleeding , 2019, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[2]  J. Lau,et al.  High Rate of Mortality More Than 30 Days After Upper Gastrointestinal Bleeding. , 2017, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[3]  J. Akiyama,et al.  Acute Severe Gastrointestinal Tract Bleeding Is Associated With an Increased Risk of Thromboembolism and Death , 2017, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[4]  N. Bhala,et al.  Stopping antithrombotic therapy after acute upper gastrointestinal bleeding is associated with reduced survival , 2017, Postgraduate Medical Journal.

[5]  H. Paajanen,et al.  Long-term mortality and causes of death in endoscopically verified upper gastrointestinal bleeding: comparison of bleeding patients and population controls , 2017, Scandinavian journal of gastroenterology.

[6]  M. Murphy,et al.  Acute lower GI bleeding in the UK: patient characteristics, interventions and outcomes in the first nationwide audit , 2017, Gut.

[7]  Michael Schultz,et al.  Comparison of risk scoring systems for patients presenting with upper gastrointestinal bleeding: international multicentre prospective study , 2017, British Medical Journal.

[8]  M. Mizokami,et al.  Development and Validation of a Risk Scoring System for Severe Acute Lower Gastrointestinal Bleeding. , 2016, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[9]  F. Chan,et al.  Risks of Bleeding Recurrence and Cardiovascular Events With Continued Aspirin Use After Lower Gastrointestinal Hemorrhage. , 2016, Gastroenterology.

[10]  W. Angerson,et al.  Antithrombotic drugs and non-variceal bleeding outcomes and risk scoring systems: comparison of Glasgow Blatchford, Rockall and Charlson scores , 2016, Frontline Gastroenterology.

[11]  E. Tapper,et al.  High Glasgow Blatchford Score at admission is associated with recurrent bleeding after discharge for patients hospitalized with upper gastrointestinal bleeding , 2015, Endoscopy.

[12]  E. Tapper,et al.  Risk Factors for Adverse Outcomes in Patients Hospitalized With Lower Gastrointestinal Bleeding. , 2015, Mayo Clinic proceedings.

[13]  D. Witt,et al.  Thromboembolic events, recurrent bleeding and mortality after resuming anticoagulant following gastrointestinal bleeding , 2015, Thrombosis and Haemostasis.

[14]  Á. Lanas,et al.  Risk of upper and lower gastrointestinal bleeding in patients taking nonsteroidal anti-inflammatory drugs, antiplatelet agents, or anticoagulants. , 2015, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[15]  D. Rockey,et al.  Aspirin Has a Protective Effect Against Adverse Outcomes in Patients with Nonvariceal Upper Gastrointestinal Bleeding , 2015, Digestive Diseases and Sciences.

[16]  M. Mizokami,et al.  Recurrence and mortality among patients hospitalized for acute lower gastrointestinal bleeding. , 2015, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[17]  E. Tapper,et al.  The Risks of Thromboembolism Vs. Recurrent Gastrointestinal Bleeding after Interruption of Systemic Anticoagulation in Hospitalized Inpatients With Gastrointestinal Bleeding: A Prospective Study , 2015, The American Journal of Gastroenterology.

[18]  Kassem Barada,et al.  Opposing effects of aspirin and anticoagulants on morbidity and mortality in patients with upper gastrointestinal bleeding , 2014, Journal of digestive diseases.

[19]  Zaid Alirhayim,et al.  Restarting anticoagulation and outcomes after major gastrointestinal bleeding in atrial fibrillation. , 2014, The American journal of cardiology.

[20]  E. Björnsson,et al.  Lower gastrointestinal bleeding: incidence, etiology, and outcomes in a population-based setting , 2013, European journal of gastroenterology & hepatology.

[21]  W. Ageno,et al.  Risk of thromboembolism, recurrent hemorrhage, and death after warfarin therapy interruption for gastrointestinal tract bleeding. , 2012, Archives of internal medicine.

[22]  I. Tawil,et al.  Should More Patients Continue Aspirin Therapy Perioperatively?: Clinical Impact of Aspirin Withdrawal Syndrome , 2012, Annals of surgery.

[23]  S. Travis,et al.  Acute upper gastrointestinal bleeding in the UK: patient characteristics, diagnoses and outcomes in the 2007 UK audit , 2011, Gut.

[24]  V. Wong,et al.  High incidence of mortality and recurrent bleeding in patients with Helicobacter pylori-negative idiopathic bleeding ulcers. , 2009, Gastroenterology.

[25]  Á. Lanas,et al.  Time Trends and Impact of Upper and Lower Gastrointestinal Bleeding and Perforation in Clinical Practice , 2009, The American Journal of Gastroenterology.

[26]  V. Garrigues,et al.  Outcome of Non-Variceal Acute Upper Gastrointestinal Bleeding in Patients with Antithrombotic Therapy , 2009, Digestion.

[27]  J. Plumb,et al.  Warfarin treatment in patients with atrial fibrillation: observing outcomes associated with varying levels of INR control. , 2009, Thrombosis research.

[28]  R. Cestari,et al.  Predictive Factors of Mortality From Nonvariceal Upper Gastrointestinal Hemorrhage: A Multicenter Study , 2008, The American Journal of Gastroenterology.

[29]  M. Mutinga,et al.  Validation of a Clinical Prediction Rule for Severe Acute Lower Intestinal Bleeding , 2005, The American Journal of Gastroenterology.

[30]  H B Devlin,et al.  Risk assessment after acute upper gastrointestinal haemorrhage. , 1996, Gut.

[31]  J. Gold,et al.  Validation of a combined comorbidity index. , 1994, Journal of clinical epidemiology.

[32]  M. Bottai,et al.  Discontinuation of low-dose aspirin therapy after peptic ulcer bleeding increases risk of death and acute cardiovascular events. , 2013, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[33]  B. Eliasson,et al.  Variability of INR and its relationship with mortality, stroke, bleeding and hospitalisations in patients with atrial fibrillation. , 2012, Thrombosis research.

[34]  N. Talley.  Continuation of Low-Dose Aspirin Therapy in Peptic Ulcer Bleeding: A Randomized Trial , 2010 .

[35]  D. Graham,et al.  Gastric adaptation. Studies in humans during continuous aspirin administration. , 1988, Gastroenterology.